dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer

OBJECTIVES: Decreased deoxycytidine kinase (dCK) expression is a reported indicator of gemcitabine efficacy in pancreatic cancer, due to the impact of this kinase on gemcitabine metabolism. The transcription factor NF‐E2 p45‐related factor 2 (NRF2, also called Nfe2l2), a master regulator of redox ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qiangsheng, Qin, Yi, Xiang, Jinfeng, Liu, Wensheng, Xu, Wenyan, Sun, Qiqing, Ji, Shunrong, Liu, Jiang, Zhang, Zheng, Ni, Quanxing, Xu, Jin, Yu, Xianjun, Zhang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528851/
https://www.ncbi.nlm.nih.gov/pubmed/29701272
http://dx.doi.org/10.1111/cpr.12456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528851/
https://www.ncbi.nlm.nih.gov/pubmed/29701272
http://dx.doi.org/10.1111/cpr.12456

Ejemplares similares